Congestive hepatopathy among patients hospitalized with decompensated heart failure
https://doi.org/10.52485/19986173_2023_4_34
Abstract
The aim of the research: The goal of the study was to assess the incidence of congestive hepatopathy (CHP) among patients hospitalized with acute decompensation of chronic heart failure (ADHF), to characterize the group with CHP, to identify features and to assess the impact on the patient's prognosis.
Materials and methods. A retrospective assessment of 228 clinical records of patients hospitalized with ADHF was performed. The analysis of the clinic, instrumental and laboratory data was carried out.
Result. Signs of CHP were detected in 92 (41,6%) hospitalized patients. CHP was more common among men than among women. The presence of CHP was associated with a higher frequency of detection of systolic dysfunction. An increase in the concentration of gamma-lutamyltranspeptidase and bilirubin in the blood was more often detected among patients with CHP. There were no significant differences in the semi-annual prognosis.
Conclusion. Hepatomegaly in patients hospitalized with decompensation of chronic heart failure, even in the absence of a vena cava inferiorcollapse on inspiration of more than 50%, cannot be the only criterion for CHP. CHP is characterized by impaired liver function in the form of an increase in the level of bilirubin and gamma-glutamyltranspeptidase. The study did not find the effect of CHP on the prognosis of life. However, the imperfection of the criteria for the diagnosis of CHP probably does not allow accurate diagnosis of CHP. Further studies of the prognostic value of CHP in patients with ADHF should most likely be carried out with an emphasis on the condition of the liver vessels (such as collapse of the hepatic veins on inspiration or ectasia of the veins as a sign of venous congestion or an increase in the diameter of vena cava inferior and hepatic veins - a symptom of Playboy Bunny), which is not determined in routine practice.
About the Authors
A. V. Iosifov
Krasnoyarsk interdistrict Clinical Hospital of emergency medical care named after N.S. Karpovich; Krasnoyarsk State Medical University named after professor V.F. Vojno-Yasenetsky
Russian Federation
Russian Federation
17 Kurchatova str., Krasnoyarsk, 660062
1 Partizana Zheleznyaka str., Krasnoyarsk, 660022
O. A. Shtegman
Krasnoyarsk interdistrict Clinical Hospital of emergency medical care named after N.S. Karpovich; Krasnoyarsk State Medical University named after professor V.F. Vojno-Yasenetsky
Russian Federation
Russian Federation
17 Kurchatova str., Krasnoyarsk, 660062
1 Partizana Zheleznyaka str., Krasnoyarsk, 660022
V. A. Babushkin
Krasnoyarsk State Medical University named after professor V.F. Vojno-Yasenetsky
Russian Federation
Russian Federation
1 Partizana Zheleznyaka str., Krasnoyarsk, 660022
References
1. Savarese G., Becher P.M., Lund L.H., etal. Global burden of heart failure: a comprehensive and updated review of epidemiology. CardiovascRes. 2023. 118(17). 32723287. doi: 10.1093.cvr.cvac013.
2. Vinogradova N.G., Polyakov D.S., Fomin I.V. Analysis of mortality in patients with heart failure after decompensation during long-term follow-up in specialized medical care and in real clinical practice. Kardiologiia. 2020. 60(4). 91-100. in Russian.
3. Yin J., LuX., Qian Z., et al. New insights into the pathogenesis and treatment of sarcopeniain chronic heart failure. Theranostics. 2019. 9(14). 4019-4029. doi: 10.7150.thno.33000
4. Fortea JI., Puente Á., Cuadrado A., et al. Congestive Hepatopathy. Int J MolSci. 2020 Dec 10. 21(24). 9420. DOI: 10.3390.ijms21249420.
5. Kobalava Z.D., Villevalde S.V., Soloveva A.E. Peoples Friendship University (RUDN), Moscow, Russia. Cardio-hepatic Syndrome in Heart Failure: Prevalence, Pathogenesis and Prognostic Significance. Kardiologia. 2016. 56(12). 63-71. DOI: 10.18565.cardio.2016.12.63-71. in Russian.
6. Lyapina I.N., Zavyrylina P.N., NachevaL.V. Intestinal microbiota – a new risk factor in cardiovascular diseases. Siberian Medical Review. 2021. (4). 26-33. DOI: 10.20333/25000136-2021-4-26-33. in Russian.
7. Allen L.A., Felker G.M., Pocock S., et al. CHARM Investigators. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J HeartFail. 2009. 11(2). 170-7. DOI: 10.1093.eurjhf.hfn031.
8. Ohara H., Yoshihisa A., Ishibashi S., et al. Hepatic Venous Stasis Index Reflects Hepatic Congestionand Predicts Adverse Outcomesin Patients With Heart Failure. J Am Heart Assoc. 2023. 12(12). e029857. DOI: 10.1161.JAHA.122.029857.
9. Poelzl G., Eberl C., Achrainer H., et al. Prevalence and prognostics ignificance of elevatedglutamyltransferasein chronic heart failure. Circ. Heart Fail. 2009. 2. 294-302.
10. Aliyeva A.M., Baykova I.E., Reznik E.V. et al. Heart-type fatty acid binding protein: the promising biological marker in heart failure. Russian Medical Inquiry. 2022. 6(1). 5-11. DOI: 10.32364.2587-6821-2022-6-1-5-11. in Russian.
11. Younossi Z.M., Golabi P., Paik J.M., et al. The global epidemiology of nonalcoholicfattyliver disease(NAFLD) and nonalcoholicsteatohepatitis (NASH): asystematicreview. Hepatology. 2023. 77(4). 1335-1347. DOI: 10.1097.HEP.0000000000000004.
12. Shipovskaya A.A., Dudanova O.P. Intrahepatic Cholestasisin Nonalcoholic FattyLiver Disease. Therapeutic Archive. 2018. 90(2). 69-74. DOI: 10.26442.terarkh201890269-74. in Russian.
13. Yudin A.L., Afukova O.A., Klyanshin A.A., et al. Visualization of Congestive Hepatopathy. Zhurnal Meditsinskaya vizualizatsiya. 2016. (5). 59-66. in Russian.
Review
For citations:
Iosifov A.V., Shtegman O.A., Babushkin V.A. Congestive hepatopathy among patients hospitalized with decompensated heart failure. Transbaikalian Medical Bulletin. 2023;(4):34-41. (In Russ.) https://doi.org/10.52485/19986173_2023_4_34
Views:
147
Email this article 